亚洲社会药学

• 论文 • 上一篇    下一篇

SWOT Analysis and Development Suggestions on HK Drugs of G Pharmaceutical Firm

Fu Yang, Tian Lijuan*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2019-06-20 发布日期:2019-06-28

SWOT Analysis and Development Suggestions on HK Drugs of G Pharmaceutical Firm

Fu Yang, Tian Lijuan*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2019-06-20 Published:2019-06-28
  • Contact: Tian Lijuan, associate professor. Major research area: drug laws and regulations, drug policies, rational drug use, drug regulatory history. Tel: 15840095857, E-mail: tianlijuan_8@126.com.

摘要: Objective To make a SWOT analysis on HK drugs, the main gynecologic biological medicament of G pharmaceutical firm, and to put forward some suggestions for the future promotion and sustainable development of the drugs. Methods SWOT analysis mode was used to study the strengths, weaknesses, opportunities and the threats that the HK drugs of G pharmaceutical firm are having. Results and Conclusion HK drugs of G pharmaceutical firm should make good use of its own advantages and external opportunities, rely on professional self-management team, and strengthen marketing promotion and brand publicity to achieve better development.

关键词: pharmaceutical firm, SWOT analysis, biotechnology industry

Abstract: Objective To make a SWOT analysis on HK drugs, the main gynecologic biological medicament of G pharmaceutical firm, and to put forward some suggestions for the future promotion and sustainable development of the drugs. Methods SWOT analysis mode was used to study the strengths, weaknesses, opportunities and the threats that the HK drugs of G pharmaceutical firm are having. Results and Conclusion HK drugs of G pharmaceutical firm should make good use of its own advantages and external opportunities, rely on professional self-management team, and strengthen marketing promotion and brand publicity to achieve better development.

Key words: pharmaceutical firm, SWOT analysis, biotechnology industry